Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Markets
Screener
News
About

HQY - HealthEquity, Inc. Latest News | Finranks

Home

HQY

H

HealthEquity, Inc. (HQY)

NMS – Real Time Price. Currency in USD

82.51

-1.34 (-1.60%)

At close: Mar 27, 2026, 4:00 PM EDT

82.51

0.00 (0.00%)

After-hours: Mar 27, 2026, 4:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

SOLV or HQY: Which Is the Better Value Stock Right Now?

SOLV or HQY: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical Services sector have probably already heard of Solventum (SOLV) and HealthEquity (HQY). But which of these two stocks presents investors with the better value opportunity right now?

HealthEquity Analysts Cut Their Forecasts After Q4 Results

HealthEquity Analysts Cut Their Forecasts After Q4 Results

Healthequity Inc (NASDAQ: HQY) posted better-than-expected earnings for the fourth quarter on Tuesday.

HealthEquity: Attractive Given Improved Cash Economics (Rating Upgrade)

HealthEquity: Attractive Given Improved Cash Economics (Rating Upgrade)

HealthEquity is upgraded to a buy, with ~25% upside potential over the next year as custodial revenue normalizes and legislative tailwinds strengthen. Shares trade at ~17x forward earnings, with EPS expected to grow 15% in FY27 and at least 10% in calendar 2027, driven by repricing of cash yields. Secular HSA account growth, an improved legislative environment, and rising custodial yields underpin HQY's earnings visibility and margin expansion.

HealthEquity, Inc. (HQY) Q4 2026 Earnings Call Transcript

HealthEquity, Inc. (HQY) Q4 2026 Earnings Call Transcript

HealthEquity, Inc. (HQY) Q4 2026 Earnings Call Transcript

Compared to Estimates, HealthEquity (HQY) Q4 Earnings: A Look at Key Metrics

Compared to Estimates, HealthEquity (HQY) Q4 Earnings: A Look at Key Metrics

The headline numbers for HealthEquity (HQY) give insight into how the company performed in the quarter ended January 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

HealthEquity (HQY) Beats Q4 Earnings and Revenue Estimates

HealthEquity (HQY) Beats Q4 Earnings and Revenue Estimates

HealthEquity (HQY) came out with quarterly earnings of $0.95 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.69 per share a year ago.

HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook

HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook

Highlights of the fiscal year include: Revenue increased 9% to $1.31 billion. Net income increased 123% to $215.2 million, and net income margin increased to 16% from 8% last year.

Videos

Final Trades: Taiwan Semi, HealthEquity, CBOE Global Markets and the XBI

Press releases

HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook

HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook

Highlights of the fiscal year include: Revenue increased 9% to $1.31 billion. Net income increased 123% to $215.2 million, and net income margin increased to 16% from 8% last year.

HealthEquity Delivers Record Q4 and Standout Fiscal 2026 Sales Metrics

HealthEquity Delivers Record Q4 and Standout Fiscal 2026 Sales Metrics

DRAPER, Utah, Feb. 17, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation's largest health savings account (“HSA”) custodian by number of accounts and leading provider of complementary consumer-directed benefits (“CDBs”), today announced its HSAs, HSA Assets, and Total Accounts as of its fiscal year ended January 31, 2026. The Company also reaffirmed its guidance for fiscal 2026 and 2027, provided an updated HSA cash repricing schedule, and announced upcoming events and presentations.

HealthEquity Reports Third Quarter Ended October 31, 2025 Financial Results

HealthEquity Reports Third Quarter Ended October 31, 2025 Financial Results

Highlights of the third quarter include: Revenue increased 7% to $322.2 million. Net income per diluted share rose to $0.59 from $0.06 one year ago, and non-GAAP net income per diluted share increased 29% to $1.01.

HealthEquity to Enhance Member Experience with Agentic AI

HealthEquity to Enhance Member Experience with Agentic AI

DRAPER, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (Nasdaq: HQY), the nation's largest Health Savings Account (HSA) and consumer-directed benefits administrator, today announced a new development in building upon its technology investments to transform member experience. The company will deploy agentic AI capabilities that fundamentally change how members access support, working with leading customer experience (CX) agent builder Parloa to mark a significant evolution in leveraging intelligent, conversational AI that understands member needs and takes action in real time.